UBC experts are available to comment on Health Canada’s approval of the Pfizer-BioNTech vaccine for adolescents aged 12 and up.
- COVID-19 in children
- Clinical trials on COVID-19 and COVID-19 vaccines
- Efficacy and safety of COVID-19 vaccines
- Pediatric infectious disease expert
- Co-principal investigator of the Canadian Treatments for COVID-19 (CATCO) trial
- Vaccine hesitancy, health communications, COVID-19 communications, communicating with anti-vaxxers
*Unavailable on Wednesday between 1–4 p.m.